State of Oncology Practice in CT: Pathways, Payers, MACRA, MIPS, USP, Value, Quality...what does the future hold and how are we going to best continue to care for our patients? An Overview and engaging discussion with Dinesh Kapur, MD, & Dawn Holcombe

When
16 Mar 2016
6:00 PM - 8:30 PM
Location
Sheraton Hartford South, Rocky Hill CT

Registration

CT Oncology practice member
Any physician, nurse, staff, resident or fellow working in a Connecticut oncology practice, private or hospital based, is invited to join CT Oncology Association meetings for free - we just ask that you register for room and food planning.
CTOA Additional Pharma or Non member Pharma – $50.00
This registration category applies to all industry staff who are either not Corporate Partners of CtOA or who are seeking to register beyond the two registrations allowed to Corporate Partners of CtOA

please contact Dawn Holcombe at dawnho@aol.com with any questions.
CTOA Corporate Partner
CTOA Corporate Partners have two registrations for each meeting available to them as part of their partnership. Additional registrations will be available, space permitting.

Registration is closed

Pathways, Payers, MACRA, MIPS, USP, Value and Quality. These issues are affecting both private and hospital-based practices. Join Dr. Kapur and Dawn Holcombe for an overview of these varied topics, and then an energetic discussion with the physicians and practice leaders of CT to define both approaches and standards that the CT oncology community feels necessary to maintain quality care for our patients.

Dinesh Kapur, MD, Eastern Connecticut Hematology Oncology, in Norwich, and President of the Connecticut Oncology Association

Dawn Holcombe, MBA, FACMPE, ACHE, is the President of DGH Consulting and the Executive Director of the Connecticut Oncology Association

Connecticut Oncology Association (CtOA)

c/o Dawn Holcombe

dawnho@aol.com

33 Woodmar Circle
South Windsor, CT 06074
(860) 305-4510

Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds